Immune-mediated and eosinophilic gastrointestinal disorders are increasingly recognized as important causes of chronic GI symptoms across all age groups. These conditions arise from dysregulated immune responses involving eosinophils, mast cells, and cytokine-mediated inflammation, often without overt structural abnormalities. Patients may present with abdominal pain, dysphagia, diarrhea, weight loss, or malnutrition. Advances in endoscopic techniques, histopathology, and molecular profiling have improved diagnostic accuracy. Management strategies include dietary interventions, pharmacologic immunomodulation, and emerging biologic therapies targeting specific inflammatory pathways. This topic highlights evolving insights into disease mechanisms, diagnostic challenges, and novel treatment approaches aimed at reducing inflammation and improving patient quality of life.
Title : Gastroenterology viewed through a glass darkly an IDI perspective
Gilles R G Monif, University of Florida and Infectious Diseases Incorporated, United States
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena Hospital, Italy
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil